Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heiko Babel

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
BMC Systems Biology|April 29, 2016
Molecular and cellular factors control signal transduction via switchable allosteric modulator proteins (SAMPs)Heiko Babel, Ilka B Bischofs
Biotechnology for Biofuels|December 9, 2020
Evolutionary engineering of E. coli MG1655 for tolerance against isoprenolHeiko Babel, Jens O Krömer
Biotechnology and Bioengineering|January 18, 2025
Reducing Structural Nonidentifiabilities in Upstream Bioprocess Models Using Profile-LikelihoodHeiko Babel, Ola Omar, Albert Paul, et al.
Journal of Clinical Pharmacology|May 29, 2026
Population Pharmacokinetics and Exposure-Response Analyses for Ubrogepant Efficacy and Safety in the Acute Treatment of Migraine: Analysis of Phase 1-3 StudiesSven Stodtmann, Lucia Siovitz, Heiko Babel, et al.
Nature Communications|March 6, 2020
Ratiometric population sensing by a pump-probe signaling system in Bacillus subtilisHeiko Babel, Pablo Naranjo-Meneses, Stephanie Trauth, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 26, 2026
Population Pharmacokinetics and Exposure-Response Analyses for Telisotuzumab Vedotin in Patients With c-Met Protein Overexpressing TumorsHeiko Babel, Priya Brunsdon, Benjamin Engelhardt, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
BMC Systems Biology|April 29, 2016
Molecular and cellular factors control signal transduction via switchable allosteric modulator proteins (SAMPs)Heiko Babel, Ilka B Bischofs
Biotechnology for Biofuels|December 9, 2020
Evolutionary engineering of E. coli MG1655 for tolerance against isoprenolHeiko Babel, Jens O Krömer
Biotechnology and Bioengineering|January 18, 2025
Reducing Structural Nonidentifiabilities in Upstream Bioprocess Models Using Profile-LikelihoodHeiko Babel, Ola Omar, Albert Paul, et al.
Journal of Clinical Pharmacology|May 29, 2026
Population Pharmacokinetics and Exposure-Response Analyses for Ubrogepant Efficacy and Safety in the Acute Treatment of Migraine: Analysis of Phase 1-3 StudiesSven Stodtmann, Lucia Siovitz, Heiko Babel, et al.
Nature Communications|March 6, 2020
Ratiometric population sensing by a pump-probe signaling system in Bacillus subtilisHeiko Babel, Pablo Naranjo-Meneses, Stephanie Trauth, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 26, 2026
Population Pharmacokinetics and Exposure-Response Analyses for Telisotuzumab Vedotin in Patients With c-Met Protein Overexpressing TumorsHeiko Babel, Priya Brunsdon, Benjamin Engelhardt, et al.
Pageof 1